Silveray Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2018

Location

Stockport UK

Primary Industry

Medical Devices & Equipment

About

Based in the UK, and founded in 2018, Silveray operates as a MedTech company. The company is a spin-out of the Advanced Technology Institute (ATI). The company was founded by its CEO Dan Cathie, and CSO Ravi Silva CBE. In November 2024, Silveray raised GBP 4 million in seed funding led by Northern Gritstone, with participation from Empirical Ventures, Deeptech Labs, Hamamatsu Ventures USA, ACF Investors, and other unspecified investors. Silveray develops and provides X-ray detectors for various medical applications. The company offers X-ray imaging technology made up of an X-ray conversion material that produces high-quality images while scanning with direct conversion detectors. The company will use the November 2024 funding to finalize the development of its DXF product for an industrial launch in 2025.

Current Investors

Cambridge Angels Group, ACF Investors, SyndicateRoom

Request a demo to show more

Primary Industry

Medical Devices & Equipment

Sub Industries

Diagnostic, Medical & Imaging Laboratories, Diagnostic Equipment

Website

www.silveray.co.uk

Verticals

HealthTech, Manufacturing, Nanotechnology

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.